Skip to main content
SpringerLink
Log in

High prices of cancer drugs in the US not just about R&D

  • Non-clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Kantarjian HM, et al. Cancer Drugs in the United States: Justum Pretium - The Just Price. Journal of Clinical Oncology 31: No. 28, 1 Oct 2013. Available from: URL: http://dx.doi.org/10.1200/JCO.2013.49.1845

    Google Scholar 

  2. Pfister DG. The Just Price of Cancer Drugs and the Growing Cost of Cancer Care: Oncologists Need to Be Part of the Solution. Journal of Clinical Oncology 31: No. 28, 1 Oct 2013. Available from: URL: http://dx.doi.org/10.1200/JCO.2013.50.3466

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

High prices of cancer drugs in the US not just about R&D. PharmacoEcon Outcomes News 689, 4 (2013). https://doi.org/10.1007/s40274-013-0783-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-013-0783-x

Search

Navigation